Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 26, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • New metabolic methods for the treatment of Glaucoma

More about Fractional Response Analysis

Flavored E-cigarettes cause lung cell toxicity

New metabolic methods for the treatment of Glaucoma
  • BiotechToday
  • World

New metabolic methods for the treatment of Glaucoma

bioxone December 19, 2020December 18, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA

The incurable eye disease Glaucoma leads to partial or total vision loss in approximately 80 million people. Therefore, it was extremely crucial to find a way around this complicated disease; the relation between metabolic disturbance in the nerve cells in the retina and high intraocular pressure. Moreover, in animal models, scientists have found a blockage in the cell’s ability to change glucose into other capable molecules, one of that is pyruvate.

The three main risk factors in glaucoma are genetic predisposition, high intraocular pressure, and age. There is only one treatment currently available for this disease is to target the pressure point in the eye with eye drops or surgery; even then, the risk of blindness in one eye is very high. 

Witnessing the risks involved analyzers specifically studied the correlation between eye pressure points and a low amount of pyruvate. When an extra layer of pyruvate was added, it worked as a protective layer in animal models during clinical trials. This connection needs to be studied more closely. Later tissue models, RNA sequencing, metabolomics can help give results. Meanwhile, advanced developments to improve the metabolism of retinal cells are also underway.

Studying glaucoma for many years, now the advances have seen an improved version of vision in participants. On the other hand, research for a new biomarker for the disease is underway. The researchers are enthusiastic about this discovery and have given optimistic statements to support this development.

Also read:More about Fractional Response Analysis

Citation: Rubio, N.R., Xiang, N. & Kaplan, D.L. Plant-based and cell-based approaches to meat production. Nat Commun 11, 6276 (2020). https://doi.org/10.1038/s41467-020-20061-y

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged biomarkers blindness eye disease genetic predisposition glaucoma metabolic disorder metabolism nerve cells pyruvate

One thought on “New metabolic methods for the treatment of Glaucoma”

  1. Pingback: Flavored E-cigarettes cause lung cell toxicity - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Flavored E-cigarettes cause lung cell toxicity

bioxone December 19, 2020

Sristi Raj Rai, Amity University Kolkata Cigarettes are getting replaced by E-cigarettes or vaping devices where most of them are flavored. The flavorings are added to the E-liquid which also consists of propylene glycol, vegetable glycerine, and nicotine usually. This liquid produces aerosol (vapor) when heated with the help of a battery. Vapors, when inhaled, […]

E-cigarettes

Related Post

  • BiotechToday
  • World

Chemotaxis – Driven 2D Nanosheet for drug delivery

bioxone October 17, 2020October 17, 2020

Saptaparna Pal, Amity University Kolkata Nano sealed motor particles represents a group of efficient molecules that can precisely respond to the biological microenvironment and improves therapeutic results. Hence, a 2D nanosheet based catalytic nanometre with chemotaxis behaviour is designed for enhanced and advanced drug delivery towards the Tumor microenvironment. The 2D structure of nanometre allows […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • Latest
  • World

Can antibody existence ensure protection against COVID-19?

bioxone September 12, 2020September 12, 2020

–Sayak Banerjee, Amity University Kolkata Due to concerns over India’s Covid-19 sharp ascend, the critical issue of antibodies poses a struggle for the scientists as they try to understand its impact on the disease progression. They stated that, while neutralizing antibodies (nAbs) generated against the SARS-Cov-2 may inhibit its entry into the host cell, other […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Studying p38-MAPK – A signaling pathway in mice embryos

BioTech Today July 17, 2021July 17, 2021

Agrima Bhatt, Rajasthan University In previous studies, p38-MAPK was identified as a regulator for blastocyst ICM fate in the mouse embryo. Today, scientists are trying to find out the functional role of the DDX21 protein. For the understanding of this complex pathway, let’s first deep dive into the embryo and its development stages. Fusion of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy